Pharmaventures Limited & Matrix Corporate Capital

LONDON and OXFORD, England, March 15, 2010 - Matrix Corporate Capital ("Matrix") and PharmaVentures Limited ("PharmaVentures") today announced the signing of a Memorandum of Understanding ("MOU") covering strategic transactions in the biotech, pharmaceutical and med tech sectors.